Respiratory adverse effects of Sofosbuvir-based regimens for treatment of chronic hepatitis C virus

Conclusion Sofosbuvir-based regimens used for treatment of chronic HCV infection are considered safe with minor respiratory adverse effects. However, larger multicenter studies are required for further assessment. Graphical abstract
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research